Low Concentrations of Beta-carotene Stimulate the Proliferation of Human Pancreatic Duct Epithelial Cells in a PKA-dependent Manner
Background: Pancreatic ductal adenocarcinoma (PDAC) is among the most common causes of cancer death. Preclinical and clinical studies on the preventive effects of beta-carotene or other retinoids have used dietary supplements that yielded high systemic concentrations (1-50 μM). While some of the pr...
Gespeichert in:
Veröffentlicht in: | Cancer genomics & proteomics 2007, Vol.4 (1), p.35-42 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background: Pancreatic ductal adenocarcinoma (PDAC) is among the most common causes of cancer death. Preclinical and clinical
studies on the preventive effects of beta-carotene or other retinoids have used dietary supplements that yielded high systemic
concentrations (1-50 μM). While some of the preclinical data suggested cancer preventive effects of these agents, they have
disappointed in clinical investigations. Materials and Methods: The effects of low concentrations (10 fM-200 nM)of beta-carotene
on the proliferation, intracellular cAMP levels, PKA activation status and phosphorylation of EGFR-specific tyrosine kinases
and ERK1/2 in immortalized human pancreatic duct epithelial cells was investigated. Results: Our data show significant concentration-dependent
and PKA-dependent stimulation of all measured endpoints. Similar responses were achieved with forskolin. Our data indicate
that low concentrations of beta-carotene stimulate the proliferation of the putative origin of PDAC, pancreatic duct epithelial
cells via cAMP and PKA-dependent transactivation of the EGFR pathway. This could potentially have promoting effects on the
development of PDAC. |
---|---|
ISSN: | 1109-6535 |